Controversy Surrounds Hepatitis B Vaccine and CDC Decisions
TL;DR Summary
A federal vaccine advisory committee is considering changing the recommendation for hepatitis B vaccination in newborns, which has been a public health success in reducing infections. The move has sparked debate due to concerns about safety, trust, and potential increases in hepatitis B cases if delayed, with many health organizations advocating to continue the current practice of vaccinating at birth.
- What to know about the hepatitis B shot — and why Trump officials are targeting it AP News
- Opinion | The CDC’s next anti-vaccine clown show is coming. Take your seats. The Washington Post
- RFK Jr.'s vaccine panel could soon upend the hepatitis B vaccine. What to know USA Today
- Kennedy’s handpicked CDC advisers to weigh major change to childhood vaccine schedule CNN
- What to know about the hepatitis B shot for infants ahead of CDC vaccine panel meeting ABC News
Reading Insights
Total Reads
0
Unique Readers
4
Time Saved
5 min
vs 6 min read
Condensed
94%
1,082 → 60 words
Want the full story? Read the original article
Read on AP News